Bicycle Therapeutics (BCYC)
(Real Time Quote from BATS)
$7.41 USD
-0.15 (-1.98%)
Updated Aug 7, 2025 10:40 AM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Bicycle Therapeutics PLC Sponsored ADR has a market cap of $523.56M, which represents its share price of $7.56 multiplied by its outstanding shares number of 69.25M. As a small-cap company, BCYC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BCYC 7.41 -0.15(-1.98%)
Will BCYC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BCYC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCYC
Entrada Therapeutics (TRDA) Soars 5.6%: Is Further Upside Left in the Stock?
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?
BCYC: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Bicycle Therapeutics (BCYC) a New Buy Stock
Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?
Other News for BCYC
Bicycle Therapeutics (BCYC) Target Price Reduced by RBC Capital | BCYC Stock News
Bicycle Therapeutics (BCYC) Price Target Reduced by RBC Capital | BCYC Stock News
Bicycle Therapeutics price target lowered by $7 at RBC Capital, here's why
Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BCYC ...